|
Oct 10
|
AB Science: Revenues for the first half of 2024 and update on AB Science’s activities
|
|
Jan 15
|
AB Science receives notice of allowance for European patent covering masitinib until 2036 in the treatment of mastocytosis
|
|
Nov 28
|
AB Science will host a live webcast on Thursday November 30, 2023, from 3pm to 4pm CET, to present the masitinib development program in sickle cell disease
|
|
Nov 27
|
AB Science: The clinical development of masitinib in sickle cell disease is among the 19 winning projects under the sixth call for “Hospital-Inuversity Research in health (RHU)”
|
|
Sep 29
|
AB Science today reports its revenues for the first half of 2023 and provides an update on its activities
|